Absorbable Tissue Spacer Market Size & Growth Analysis to 2030

The global absorbable tissue spacer market size was valued at around USD 120 million in 2022 and is expected to grow at a significant growth rate (CAGR) of 10.8% during the forecast period from 2023 to 2030. This growth can be attributed to factors such as the increasing prevalence of orthopedic and musculoskeletal disorders, the rising geriatric population, and the growing demand for minimally invasive surgical procedures.

An absorbable tissue spacer is a type of implantable medical device used to maintain the space between two tissues or bones after surgery. These spacers are designed to be gradually absorbed by the body over time, eliminating the need for a second surgery to remove the implant.

The tissue spacer market is highly competitive, with several players operating in the market. Some of the key players in the absorbable tissue spacer market include Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Medtronic plc, Wright Medical Group N.V., and Integra LifeSciences Holdings Corporation.

Market Drivers:

Growing prevalence of orthopedic and musculoskeletal disorders: The increasing prevalence of orthopedic and musculoskeletal disorders, such as osteoarthritis, rheumatoid arthritis, and degenerative disc disease, is driving the demand for tissue spacers. These spacers are used to maintain the space between two tissues or bones after surgery and promote healing.

Rising geriatric population: The geriatric population is more prone to orthopedic and musculoskeletal disorders, which is expected to drive the demand for absorbable tissue spacers. According to the World Health Organization (WHO), the global population aged 60 years and above is expected to reach 2 billion by 2050.

Growing demand for minimally invasive surgical procedures: The increasing demand for minimally invasive surgical procedures is driving the adoption of absorbable tissue spacers. These spacers can be implanted using minimally invasive techniques, which results in faster recovery and fewer complications for patients.

Advancements in technology: The development of new and advanced materials, such as bioresorbable polymers, is expected to drive the growth of the absorbable tissue spacer market. These materials offer several advantages over traditional materials, such as reduced inflammation and improved biocompatibility.

Increasing awareness about tissue spacers: The growing awareness about the benefits of tissue spacers among healthcare professionals and patients is also driving the demand for absorbable tissue spacers. This is expected to continue to drive the market growth in the coming years.

Market Snapshot:

To know more about the comprehensive study, request sample papers

Market Insights:

Global Absorbable Tissue Spacers Market Analysis by Application:

The global absorbable tissue spacers market is bifurcated into product type, application, end-use, and geography. On the basis of application, the market is further segmented into radiotherapy and infection management. Absorbable tissue spacers are increasingly being used in radiotherapy applications to maintain the space between the tissues during radiation treatment and reduce radiation exposure to healthy tissues. The market for absorbable tissue spacers can be analyzed by radiotherapy, based on the use of spacers in radiation therapy.

The use of absorbable tissue spacers in radiation therapy is becoming more prevalent due to the growing demand for precise and effective radiation therapy. Absorbable tissue spacers are used to separate the target tissue from surrounding healthy tissues, reducing radiation exposure to the healthy tissue and enhancing the effectiveness of radiation therapy.

The use of absorbable tissue spacers in radiation therapy has been demonstrated in various types of cancer, including breast cancer, prostate cancer, and pancreatic cancer. In breast cancer treatment, absorbable tissue spacers are used to create a space between the chest wall and the breast tissue, reducing radiation exposure to the heart and lungs. In prostate cancer treatment, absorbable tissue spacers are used to create a space between the rectum and the prostate gland, reducing radiation exposure to the rectum. In pancreatic cancer treatment, absorbable tissue spacers are used to create a space between the pancreas and the surrounding organs, reducing radiation exposure to healthy organs.

The use of absorbable tissue spacers in radiation therapy is expected to witness significant growth in the coming years, owing to the increasing prevalence of cancer and the growing demand for precise and effective radiation therapy. The use of absorbable tissue spacers in radiation therapy is also expected to reduce the risk of side effects associated with radiation therapy and improve patient outcomes.

To know more about the comprehensive study, request sample papers

The global absorbable tissue spacer market report explores the critical analysis of the industry using key parameters. The report covers investment strategies, the need for investment in the industry, and several benefits for investors. Significantly, this report sets out major changes in the global technical regulations for the market, as well as how economic and non-economic constraints are helping the market to grow. Furthermore, the report analyzes the historic and forecasted market size at the global, regional, and country-level. The report also provides a comprehensive analysis of key investment proposals, competitor positions, porter’s five force analysis, SWOT analysis, pestel analysis, value chain analysis, etc.

The absorbable tissue spacer market research report presents the analysis of each segment from 2020 to 2030 considering 2022 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2023 to 2030.

Historical & Forecast Period

• 2020-21 – Historical Year
• 2022 – Base Year
• 2023-2030 – Forecast Period

Market Segmentation:

By Product Type:

• Hydrogel-Based Spacer
• Biodegradable Hyaluronic Acid Spacer
• Biodegradable Balloon Spacer
• Crystal-Based Spacer

By Application:

• Radiotherapy
• Infection Management

By End-Use:

• Hospitals
• Ambulatory Surgical Centres
• Specialized Clinics

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage:

Geographically, the absorbable tissue spacer market report comprises dedicated sections centering on the regional market revenue and trends. The absorbable tissue spacer market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The absorbable tissue spacer market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Absorbable tissue spacer market estimates have also been provided for the historical years 2020 & 2021 along with forecasts for the period from 2023 – 2030.

Competitive Assessment:

Some of the prominent market players operating in the global absorbable tissue spacer market are Biocomposites, Boston Scientific (Augmenix, Inc), Bioprotect Ltd., and Palette Life Sciences, Inc.Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. There have been several recent developments and product launches in the absorbable tissue spacer market. For instance:

Palette Life Sciences’ Barrigel, a hyaluronic acid rectal spacer designed to protect the prostate during radiation therapy for prostate cancer patients with T1-T3b disease, was approved by the US FDA in June 2022. This is the first and only FDA-approved product of its kind.

BioProtect® Absorbable Spacer: In 2021, the medical device company Augmenix launched the BioProtect® Absorbable Spacer for use in prostate cancer treatment. The spacer is designed to create a space between the rectum and the prostate gland, reducing the risk of radiation exposure to the rectum during radiation therapy.

DuraGen Plus® Absorbable Dural Matrix: In 2020, the medical device company Integra LifeSciences launched the DuraGen Plus® Absorbable Dural Matrix for use in neurosurgical procedures. The matrix is designed to promote healing and prevent cerebrospinal fluid leakage after neurosurgical procedures.

Key Companies:

• Biocomposites
• Boston Scientific (Augmenix, Inc)
• Bioprotect Ltd.
• Palette Life Sciences, Inc.
• Becton, Dickinson, and Company
• Integra LifeSciences
• Others

Key Questions Answered by Absorbable Tissue Spacer Market Report

• Global absorbable tissue spacer market forecasts from 2023-2030
• Regional market forecasts from 2023-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2023-2030 covering 15 major countries from the regions as mentioned above
• Absorbable tissue spacer submarket forecasts from 2023-2030 covering the market by product type, application, end-use, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level absorbable tissue spacer markets from 2023-2030
• Competitive Landscape and market positioning of the top 10 players operating in the market